Search

everythinglearnresearchcommunity

for

Search:↓

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Keratin is crucial for keeping skin cells healthy and its changes can lead to diseases and affect cell behavior.

The skin microbiome helps heal wounds and can be targeted to improve healing.

People with alopecia have a higher risk of thyroid cancer.

Inflammasome proteins can indicate the severity and treatment response of various diseases and injuries.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Paris polyphylla saponins may effectively treat acne due to their antibacterial and anti-inflammatory properties.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Asparagus racemosus and Withania somnifera can help reduce side effects of a cancer drug.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Mesenchymal Stem/Stromal Cells (MSCs) help in wound healing and tissue regeneration, but can also contribute to tumor growth. They show promise in treating chronic wounds and certain burns, but their full healing mechanisms and potential challenges need further exploration.

Secukinumab for psoriasis unexpectedly caused increased hair growth in a patient.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Calcipotriol's effectiveness for treating alopecia areata is unclear and needs more research.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Substances from Chinese medicines show promise for immune support and disease prevention, but the way they are processed affects their effectiveness.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.

IL-3 worsens lupus nephritis and blocking it improves kidney health.